ADMA Biologics Inc (ADMA)
21.28
-0.02
(-0.09%)
USD |
NASDAQ |
Nov 22, 09:47
ADMA Biologics Shareholders Equity (Quarterly): 231.89M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 231.89M |
June 30, 2024 | 188.27M |
March 31, 2024 | 153.71M |
December 31, 2023 | 135.21M |
September 30, 2023 | 151.44M |
June 30, 2023 | 146.76M |
March 31, 2023 | 145.65M |
December 31, 2022 | 151.97M |
September 30, 2022 | 100.38M |
June 30, 2022 | 114.40M |
March 31, 2022 | 126.93M |
December 31, 2021 | 141.17M |
September 30, 2021 | 102.78M |
June 30, 2021 | 111.59M |
March 31, 2021 | 112.50M |
December 31, 2020 | 88.25M |
September 30, 2020 | 71.38M |
June 30, 2020 | 76.88M |
March 31, 2020 | 96.34M |
December 31, 2019 | 26.19M |
September 30, 2019 | 36.12M |
June 30, 2019 | 46.91M |
March 31, 2019 | 10.04M |
December 31, 2018 | 19.77M |
September 30, 2018 | 37.21M |
Date | Value |
---|---|
June 30, 2018 | 51.76M |
March 31, 2018 | 23.03M |
December 31, 2017 | 40.33M |
September 30, 2017 | 12.99M |
June 30, 2017 | 27.68M |
March 31, 2017 | -10.76M |
December 31, 2016 | -4.457M |
September 30, 2016 | -0.1521M |
June 30, 2016 | 3.916M |
March 31, 2016 | -3.369M |
December 31, 2015 | 0.821M |
September 30, 2015 | 4.914M |
June 30, 2015 | 9.520M |
March 31, 2015 | 13.43M |
December 31, 2014 | 6.009M |
September 30, 2014 | 9.245M |
June 30, 2014 | 12.30M |
March 31, 2014 | 15.90M |
December 31, 2013 | 21.57M |
September 30, 2013 | -0.7358M |
June 30, 2013 | 1.728M |
March 31, 2013 | 6.401M |
December 31, 2012 | 9.424M |
September 30, 2012 | 11.61M |
June 30, 2012 | 14.66M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
26.19M
Minimum
Dec 2019
231.89M
Maximum
Sep 2024
123.69M
Average
120.67M
Median
Shareholders Equity (Quarterly) Benchmarks
Corcept Therapeutics Inc | 638.84M |
Madrigal Pharmaceuticals Inc | 777.16M |
Assembly Biosciences Inc | 26.00M |
TG Therapeutics Inc | 192.16M |
Krystal Biotech Inc | 885.85M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 390.62M |
Total Liabilities (Quarterly) | 158.73M |
Debt to Equity Ratio | 0.437 |
Current Ratio | 7.088 |
Net Debt Paydown Yield | 0.16% |